Johnson & Johnson (JNJ)vsSTERIS plc (STE)
JNJ
Johnson & Johnson
$255.88
-3.63%
HEALTHCARE · Cap: $615.36B
STE
STERIS plc
$234.83
+1.95%
HEALTHCARE · Cap: $21.23B
Smart Verdict
WallStSmart Research — data-driven comparison
Johnson & Johnson generates 1550% more annual revenue ($97.93B vs $5.94B). JNJ leads profitability with a 21.5% profit margin vs 13.2%. STE appears more attractively valued with a PEG of 1.76. STE earns a higher WallStSmart Score of 68/100 (B-).
JNJ
Buy57
out of 100
Grade: C
STE
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for JNJ.
Margin of Safety
-51.8%
Fair Value
$160.37
Current Price
$234.83
$74.46 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 25 in profit
Keeps 22 of every $100 in revenue as profit
Strong operational efficiency at 28.6%
Generating 3.4B in free cash flow
Earnings expanding 52.2% YoY
Conservative balance sheet, low leverage
Strong operational efficiency at 20.0%
Areas to Watch
Moderate valuation
Expensive relative to growth rate
Earnings declined 1.0%
Expensive relative to growth rate
Moderate valuation
Comparative Analysis Report
WallStSmart ResearchBull Case : JNJ
The strongest argument for JNJ centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 21.5% and operating margin at 28.6%.
Bull Case : STE
The strongest argument for STE centers on EPS Growth, Debt/Equity, Operating Margin.
Bear Case : JNJ
The primary concerns for JNJ are P/E Ratio, PEG Ratio, EPS Growth.
Bear Case : STE
The primary concerns for STE are PEG Ratio, P/E Ratio.
Key Dynamics to Monitor
JNJ profiles as a mature stock while STE is a value play — different risk/reward profiles.
STE carries more volatility with a beta of 0.92 — expect wider price swings.
STE is growing revenue faster at 7.3% — sustainability is the question.
JNJ generates stronger free cash flow (3.4B), providing more financial flexibility.
Bottom Line
STE scores higher overall (68/100 vs 57/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Johnson & Johnson
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
Visit Website →STERIS plc
HEALTHCARE · MEDICAL DEVICES · USA
Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?